CB2 receptor agonist 9 (Compound 33) is an orally active agonist for cannabinoid receptor 2 ( CB2 receptor ) with an EC 50 of 16.2 nM. CB2 receptor agonist 9 inhibits the expression of TNF-α, IL-1β and IL-6 , exhibits anti-inflammatory efficacy in DDS ( HY-116282 )-induced mouse acute colitis model.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Cannabinoid Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.